Valion Bio, Inc. Area of Land
Valion Bio, Inc. (VBIO) had Area of Land of 9.09 thousand sqft as of 2024-12-31, per its 10-K filed 2025-03-21.
Financial Statements › Notes
us-gaap:AreaOfLand · last filed 2025-03-21
- 2024-12-31: Area of Land 9.09K sqft.
- 2024-09-30: Area of Land 9.09K sqft.
- 2024-06-30: Area of Land 9.09K sqft.
- 2024-03-31: Area of Land 9.09K sqft.
| Period end | Area of Land |
|---|---|
| 2024-12-31 | 9.09K sqft 10-K · filed 2025-03-21 |
| 2024-09-30 | 9.09K sqft 10-Q · filed 2024-11-14 |
| 2024-06-30 | 9.09K sqft 10-Q · filed 2024-08-14 |
| 2024-03-31 | 9.09K sqft 10-Q · filed 2024-05-15 |
| 2023-12-31 | 9.09K sqft 10-K · filed 2024-03-25 |
| 2022-12-31 | 9.09K sqft 10-K · filed 2023-03-31 |
| 2022-06-30 | 9.09K sqft 10-Q · filed 2022-08-15 |
| 2022-03-31 | 9.09K sqft 10-Q · filed 2022-05-16 |
| 2021-11-30 | 9.09K sqft 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |